131 related articles for article (PubMed ID: 30586310)
1. Total Synthesis of the Antidiabetic (Type 2) Lipid Mediator Protectin DX/PDX.
Sancéau JY; Maltais R; Poirier D; Marette A
J Org Chem; 2019 Jan; 84(2):495-505. PubMed ID: 30586310
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective synthesis of protectin D1: a potent anti-inflammatory and proresolving lipid mediator.
Aursnes M; Tungen JE; Vik A; Dalli J; Hansen TV
Org Biomol Chem; 2014 Jan; 12(3):432-7. PubMed ID: 24253202
[TBL] [Abstract][Full Text] [Related]
3. A versatile and stereocontrolled total synthesis of dihydroxylated docosatrienes containing a conjugated E,E,Z-triene.
Dayaker G; Durand T; Balas L
Chemistry; 2014 Mar; 20(10):2879-87. PubMed ID: 24520010
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Identification of AceDoxyPC, a Protectin-Containing Structured Phospholipid, Using Liquid Chromatography/Mass Spectrometry.
Lo Van A; Fourmaux B; Picq M; Guichardant M; Lagarde M; Bernoud-Hubac N
Lipids; 2017 Sep; 52(9):751-761. PubMed ID: 28776175
[TBL] [Abstract][Full Text] [Related]
5. Stereocontrolled total synthesis of neuroprotectin D1 / protectin D1 and its aspirin-triggered stereoisomer.
Petasis NA; Yang R; Winkler JW; Zhu M; Uddin J; Bazan NG; Serhan CN
Tetrahedron Lett; 2012 Apr; 53(14):1695-1698. PubMed ID: 22690022
[TBL] [Abstract][Full Text] [Related]
6. Total synthesis of neuroprotectin D1 analogues derived from omega-6 docosapentaenoic acid (DPA) and adrenic acid (AdA) from a common pivotal, late-stage intermediate.
Dayaker G; Durand T; Balas L
J Org Chem; 2014 Mar; 79(6):2657-65. PubMed ID: 24571431
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of docosahexaenoic acid derivatives designed as novel PPARgamma agonists and antidiabetic agents.
Itoh T; Murota I; Yoshikai K; Yamada S; Yamamoto K
Bioorg Med Chem; 2006 Jan; 14(1):98-108. PubMed ID: 16198578
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory and anti-virus potential of poxytrins, especially protectin DX.
Lagarde M; Guichardant M; Bernoud-Hubac N
Biochimie; 2020 Dec; 179():281-284. PubMed ID: 32956736
[TBL] [Abstract][Full Text] [Related]
9. A Concise, Gram-Scale Total Synthesis of Protectin DX and Related Labeled Versions via a Key Stereoselective Reduction of Enediyne.
Maltais R; Sancéau JY; Poirier D; Marette A
J Org Chem; 2023 Jun; 88(11):7088-7095. PubMed ID: 37172290
[TBL] [Abstract][Full Text] [Related]
10. Insights in diabetes: Molecular mechanisms-Protectin DX, an anti-inflammatory and a stimulator of inflammation resolution metabolite of docosahexaenoic acid, protects against the development of streptozotocin-induced type 1 and type 2 diabetes mellitus in male Swiss albino mice.
Rengachar P; Polavarapu S; Das UN
Front Endocrinol (Lausanne); 2022; 13():1053879. PubMed ID: 36778598
[TBL] [Abstract][Full Text] [Related]
11. A role for 12/15-lipoxygenase-derived proresolving mediators in postoperative ileus: protectin DX-regulated neutrophil extravasation.
Stein K; Stoffels M; Lysson M; Schneiker B; Dewald O; Krönke G; Kalff JC; Wehner S
J Leukoc Biol; 2016 Feb; 99(2):231-9. PubMed ID: 26292977
[TBL] [Abstract][Full Text] [Related]
12. Total synthesis and bioactivities of two proposed structures of maresin.
Sasaki K; Urabe D; Arai H; Arita M; Inoue M
Chem Asian J; 2011 Feb; 6(2):534-43. PubMed ID: 21254430
[TBL] [Abstract][Full Text] [Related]
13. Solid state synthesis of docosahexaenoic acid-loaded zinc oxide nanoparticles as a potential antidiabetic agent in rats.
Hussein J; Attia MF; El Bana M; El-Daly SM; Mohamed N; El-Khayat Z; El-Naggar ME
Int J Biol Macromol; 2019 Nov; 140():1305-1314. PubMed ID: 31449866
[TBL] [Abstract][Full Text] [Related]
14. Total Synthesis of Semaglutide Based on a Soluble Hydrophobic-Support-Assisted Liquid-Phase Synthetic Method.
Liu X; Zhang N; Gu X; Qin Y; Song D; Zhang L; Ma S
ACS Comb Sci; 2020 Dec; 22(12):821-825. PubMed ID: 33058727
[TBL] [Abstract][Full Text] [Related]
15. Full characterization of PDX, a neuroprotectin/protectin D1 isomer, which inhibits blood platelet aggregation.
Chen P; Fenet B; Michaud S; Tomczyk N; Véricel E; Lagarde M; Guichardant M
FEBS Lett; 2009 Nov; 583(21):3478-84. PubMed ID: 19818771
[TBL] [Abstract][Full Text] [Related]
16. Confusion between protectin D1 (PD1) and its isomer protectin DX (PDX). An overview on the dihydroxy-docosatrienes described to date.
Balas L; Guichardant M; Durand T; Lagarde M
Biochimie; 2014 Apr; 99():1-7. PubMed ID: 24262603
[TBL] [Abstract][Full Text] [Related]
17. Identification of putative metabolites of docosahexaenoic acid as potent PPARgamma agonists and antidiabetic agents.
Yamamoto K; Itoh T; Abe D; Shimizu M; Kanda T; Koyama T; Nishikawa M; Tamai T; Ooizumi H; Yamada S
Bioorg Med Chem Lett; 2005 Feb; 15(3):517-22. PubMed ID: 15664804
[TBL] [Abstract][Full Text] [Related]
18. Identification of 14,20-dihydroxy-docosahexaenoic acid as a novel anti-inflammatory metabolite.
Yokokura Y; Isobe Y; Matsueda S; Iwamoto R; Goto T; Yoshioka T; Urabe D; Inoue M; Arai H; Arita M
J Biochem; 2014 Dec; 156(6):315-21. PubMed ID: 25012818
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes.
Serhan CN; Gotlinger K; Hong S; Lu Y; Siegelman J; Baer T; Yang R; Colgan SP; Petasis NA
J Immunol; 2006 Feb; 176(3):1848-59. PubMed ID: 16424216
[TBL] [Abstract][Full Text] [Related]
20. Stereoselective Total Synthesis of Macrophage-Produced Prohealing 14,21-Dihydroxy Docosahexaenoic Acids.
Nishimura K; Sakaguchi T; Nanba Y; Suganuma Y; Morita M; Hong S; Lu Y; Jun B; Bazan NG; Arita M; Kobayashi Y
J Org Chem; 2018 Jan; 83(1):154-166. PubMed ID: 29224348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
